The Role of Amyloid‐Beta in Blood and Cerebrospinal Fluid: Implications for Alzheimer’s Disease Diagnosis and Monitoring

Abstract

Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory impairment. One of the hallmark pathological features of AD is the accumulation of amyloid‐beta (Aβ) peptides in the brain.